Rheumatology Journals

Rheumatology

sponsor
Become a Member Today!
Register
Email:


Password:

Remember me
Forgot your Password?
Invite Code?
Article ID

Your Article Summary

(Click the title below to leave the MDLinx Network and go to the Journal's Website)

Fonnesu C et al. - Familial Mediterranean Fever (FMF) is a hereditary autosomal recessive, autoinflammatory disorder characterized by recurrent, self-limiting episodes of short duration (mean 24–72 h) of fever and serositis. The most severe long-term complication is type AA amyloidosis, principally affecting the kidney and the cause of chronic renal failure. Two types of risk factors, genetic and non-genetic, have been identified for this complication. Currently, the only effective treatment of Familial Mediterranean Fever is the colchicine.

Related Articles

MEFV mutations in Egyptian patients suffering from familial Mediterranean fever: analysis of 12 gene mutations
Rheumatology International, 10/16/09    Relevance Score: 67%

Familial Mediterranean fever gene mutations in the inner northern region of Turkey and genotype-phenotype correlation in children
Journal of Paediatrics and Child Health, 10/27/09    Relevance Score: 65%

Neutrophil-derived S100A12 as novel biomarker of inflammation in Familial Mediterranean Fever
Annals of Rheumatic Diseases, 10/01/09    Relevance Score: 65%

Heart rate variability in familial Mediterranean fever
Rheumatology International, 11/06/09    Relevance Score: 64%

Anti-IL-1 treatment for secondary amyloidosis in an adolescent with FMF and Behcets disease
Clinical Rheumatology, 10/06/09    Relevance Score: 64%


Sponsor

Article Search

Keyword:

Search:

Published within

Sort By:
Date
Relevance


Sponsor

Send this Summary to a Colleague

Enter email address